Digital Diagnostics vs Hyperfine Swoop

Hyperfine's Swoop is bought as equipment. The FY2025 10-K describes ownership, then an annual software, service and support agreement after a one-year warranty, on 36- or 60-month terms. An older Scientific Reports paper put a system at about $50,000 (currency not stated), and the 10-K sets conventional MRI at about $1.2 million on average. A hospital that wants brain MRI at the bedside, in the ICU or in a resource-limited site is the buyer. Swoop gives T1, T2, FLAIR and DWI but no contrast-enhanced T1.

Hyperfine reported preliminary third-quarter 2026 revenue of about $6.0 million, up 55%, while Yahoo Finance gives a second-quarter 2026 net loss of $9.3 million. A buyer signing a 36- or 60-month service agreement is signing with a loss-making public company.

Digital Diagnostics sells software that grades retinal photos, and a primary care practice that bills CPT 92229 is its buyer. A 2026 Scientific Reports comparison with ophthalmologist fundoscopy found an exact grade match of 54.2% and undergrading in 4.8%. The vendor claims its key trial avoided 91% of unnecessary specialty visits.

Brain MRI and diabetic eye screening are separate purchases.